Page last updated: 2024-10-28

hexamethylene bisacetamide and Chronic Disease

hexamethylene bisacetamide has been researched along with Chronic Disease in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gulisano, M1
Pacini, S1
Ruggiero, M1
Pacini, A1
Delrio, AN1
Pacini, P1

Other Studies

1 other study available for hexamethylene bisacetamide and Chronic Disease

ArticleYear
In vitro effects of some differentiation inductors in metaplastic epithelium of the human nasal cavity.
    Cell and tissue research, 1996, Volume: 285, Issue:1

    Topics: Acetamides; Cell Differentiation; Cells, Cultured; Chronic Disease; Cilia; Cryoprotective Agents; Di

1996